Extended-Release Amantadine May Help Dyskinesias
July 10, 2017

An extended-release formulation of amantadine is safe and effective for relieving troublesome dyskinesias in people with Parkinson’s disease (PD), according to a new study.  The results appear in the June 12 online edition of JAMA Neurology.  A decision on the drug’s approval by the US Food and Drug Administration (FDA) is expected this year, meaning it could be available to people with PD relatively soon.

September 17, 2017

PDF Champion Amanda Marks will run the Philadelphia Half Marathon in honor of her pop-pop who lives with Parkinson’s.

Will you go the distance for Parkinson's? We are excited to offer a limited quantity of entries in the 2017 Rock ‘n’ Roll Marathon Series.